Earnings Call · Q1 FY2021·2021-05-14

Q1 21EPS +17.31%·Rev n/aQ4 20EPS -15.91%·Rev n/aQ3 20EPS +19.61%·Rev n/aQ2 20EPS +14.58%·Rev n/a⚠ consensus missing

Trevi Therapeutics, Inc. TRVI

Jennifer Good — Chief Executive Officer

−2.4%1d on move date3d−2.5%5d−3.2%

Research tier

Behavioral profile computed for this call's speaker on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRVI calls or request research access.

More TRVI calls Browse calls Request research access